<table id="t10" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 10. Effect of Coadministered Drugs on Zidovudine AUC<sup>a</sup>
</caption>
<col align="left" span="1" width="22.137%"></col>
<col align="left" span="1" width="19.353%"></col>
<col align="left" span="1" width="7.618%"></col>
<col align="left" span="1" width="10.052%"></col>
<col align="left" span="1" width="17.786%"></col>
<col align="left" span="1" width="23.054%"></col>
<tbody>
<tr>
<td>
<content stylecode="bold">Note: ROUTINE DOSE MODIFICATION OF ZIDOVUDINE IS NOT WARRANTED WITH COADMINISTRATION OF THE FOLLOWING DRUGS.</content>
</td>
</tr>
<tr>
<td>Coadministered Drug and Dose</td>
<td>Zidovudine Dose</td>
<td>n</td>
<td>Zidovudine Concentrations</td>
<td>Concentration of Coadministered Drug</td>
</tr>
<tr>
<td>AUC</td>
<td>Variability</td>
</tr>
<tr>
<td>Atovaquone<br/>750 mg q 12 hr with food</td>
<td>200 mg q 8 hr</td>
<td>14</td>
<td>↑AUC 31%</td>
<td>Range<br/>23% to 78%<sup>b</sup>
</td>
<td>↔</td>
</tr>
<tr>
<td>Clarithromycin<br/>500 mg twice daily</td>
<td>100 mg q 4 hr x 7 days</td>
<td>4</td>
<td>↓AUC 12%</td>
<td>Range<br/>↓34% to ↑14%</td>
<td>Not Reported</td>
</tr>
<tr>
<td>Fluconazole<br/>400 mg daily</td>
<td>200 mg q 8 hr</td>
<td>12</td>
<td>↑AUC 74%</td>
<td>95% CI: 54% to 98%</td>
<td>Not Reported</td>
</tr>
<tr>
<td>Lamivudine<br/>300 mg q 12 hr</td>
<td>single 200 mg</td>
<td>12</td>
<td>↑AUC 13%</td>
<td>90% CI:<br/>2% to 27%</td>
<td>↔</td>
</tr>
<tr>
<td>Methadone<br/>30 to 90 mg daily</td>
<td>200 mg q 4 hr</td>
<td>9</td>
<td>↑AUC 43%</td>
<td>Range<br/>16% to 64%<sup>b</sup>
</td>
<td>↔</td>
</tr>
<tr>
<td>Nelfinavir<br/>750 mg q 8 hr x<br/>7 to 10 days</td>
<td>single 200 mg</td>
<td>11</td>
<td>↓AUC 35%</td>
<td>Range<br/>28% to 41%</td>
<td>↔</td>
</tr>
<tr>
<td>Probenecid<br/>500 mg q 6 hr x<br/>2 days</td>
<td>2 mg/kg q 8 hr x 3 days</td>
<td>3</td>
<td>↑AUC 106%</td>
<td>Range<br/>100% to 170%<sup>b</sup>
</td>
<td>Not Assessed</td>
</tr>
<tr>
<td>Rifampin<br/>600 mg daily x<br/>14 days</td>
<td>200 mg q 8 hr  x 14 days</td>
<td>8</td>
<td>↓AUC 47%</td>
<td>90% CI:<br/>41% to 53%</td>
<td>Not Assessed</td>
</tr>
<tr>
<td>Ritonavir<br/>300 mg q 6 hr x<br/>4 days</td>
<td>200 mg q 8 hr  x 4 days</td>
<td>9</td>
<td>↓AUC 25%</td>
<td>95% CI:<br/>15% to 34%</td>
<td>↔</td>
</tr>
<tr>
<td>Valproic acid<br/>250 mg or 500 mg q 8 hr x 4 days</td>
<td>100 mg q 8 hr  x 4 days</td>
<td>6</td>
<td>↑AUC 80%</td>
<td>Range<br/>64% to 130%<sup>b</sup>
</td>
<td>Not Assessed</td>
</tr>
<tr>
<td>
<paragraph>↑ = Increase; ↓ = Decrease; ↔= no significant change; AUC = area under the concentration versus time curve; CI = confidence interval.</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<sup>a</sup>This table is not all inclusive.
</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>
<sup>b</sup>Estimated range of percent difference.
</paragraph>
</td>
</tr>
</tbody>
</table>